A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
Introduction and Objectives: Seroclearance of hepatitis B e antigen (HBeAg) is an important treatment goal for patients with chronic hepatitis B (CHB). This study developed a nomogram for predicting HBeAg seroclearance in CHB patients treated with nucleos(t)ide analogues (NAs). Patients and Methods:...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2024-01-01
|
| Sarja: | Annals of Hepatology |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S1665268123002545 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
